SEC Form 4 insider trading filings tracked in real time from EDGAR

Vistagen Therapeutics, Inc. (VTGN) — Insider Trading

Insider trading activity for Vistagen Therapeutics, Inc. sourced from SEC EDGAR Form 4 filings.

Overview

  • Total insider trades: 8
  • Last trade date: Apr 9, 2026
  • Ticker: VTGN

Top Insiders

  • Cote Elissa S. (Chief Corp Development Officer) — 1 trades, buy: $0, sell: $0
  • Prince Joshua S. (Chief Operating Officer) — 2 trades, buy: $0, sell: $0
  • Adler Reid G. (Chief Legal Officer) — 2 trades, buy: $0, sell: $0
  • Tressler Nick B. (Chief Financial Officer) — 1 trades, buy: $0, sell: $0
  • Singh Shawn (President and CEO) — 2 trades, buy: $0, sell: $0

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Apr 7, 2026 Singh Shawn VTGN Vistagen Therapeutics, Inc. BUY 71,268 N/A
Apr 7, 2026 Singh Shawn VTGN Vistagen Therapeutics, Inc. BUY 3,732 N/A
Apr 7, 2026 Tressler Nick B. VTGN Vistagen Therapeutics, Inc. BUY 75,000 N/A
Apr 7, 2026 Adler Reid G. VTGN Vistagen Therapeutics, Inc. BUY 56,247 N/A
Apr 7, 2026 Adler Reid G. VTGN Vistagen Therapeutics, Inc. BUY 18,753 N/A
Apr 7, 2026 Prince Joshua S. VTGN Vistagen Therapeutics, Inc. BUY 56,248 N/A
Apr 7, 2026 Prince Joshua S. VTGN Vistagen Therapeutics, Inc. BUY 18,752 N/A
Apr 7, 2026 Cote Elissa S. VTGN Vistagen Therapeutics, Inc. BUY 75,000 N/A

← All companies · Full trades feed